Cargando…

Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review

Melatonin (N-acetyl-5-methoxytryptamine) is an indoleamine with antioxidant, chronobiotic and anti-inflammatory properties; reduced levels of this hormone are associated with higher risk of cancer. Several beneficial effects of melatonin have been described in a broad number of tumors, including liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Palanca, Paula, Méndez-Blanco, Carolina, Fondevila, Flavia, Tuñón, María J., Reiter, Russel J., Mauriz, José L., González-Gallego, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828223/ https://www.ncbi.nlm.nih.gov/pubmed/33445767 http://dx.doi.org/10.3390/antiox10010103

Ejemplares similares

Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
por: Fernández-Palanca, Paula, et al.
Publicado: (2019)

Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
por: Fondevila, Flavia, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis
por: Méndez-Blanco, Carolina, et al.
Publicado: (2021)

Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence
por: San‐Miguel, Beatriz, et al.
Publicado: (2022)

Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies
por: Fernández-Palanca, Paula, et al.
Publicado: (2022)

Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
por: Méndez-Blanco, Carolina, et al.
Publicado: (2019)

Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
por: Fondevila, Flavia, et al.
Publicado: (2021)

Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
por: Fondevila, Flavia, et al.
Publicado: (2021)

Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
por: Fernández-Palanca, Paula, et al.
Publicado: (2022)

Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
por: Fernández-Palanca, Paula, et al.
Publicado: (2023)

Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy
por: Prieto-Domínguez, Néstor, et al.
Publicado: (2017)

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
por: Méndez-Blanco, Carolina, et al.
Publicado: (2018)

Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral‐induced fulminant hepatic failure
por: Crespo, Irene, et al.
Publicado: (2020)

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
por: Egea, Javier, et al.
Publicado: (2022)

Melatonin as a Potential Agent in the Treatment of Sarcopenia
por: Coto-Montes, Ana, et al.
Publicado: (2016)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
por: Loh, Doris, et al.
Publicado: (2021)

The Multiple Functions of Melatonin: Applications in the Military Setting
por: Gancitano, Giuseppe, et al.
Publicado: (2022)

Melatonin as a potential inhibitory agent in head and neck cancer
por: Yeh, Chia-Ming, et al.
Publicado: (2017)

Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011)

Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia
por: Loh, Doris, et al.
Publicado: (2023)

Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
por: Loh, Doris, et al.
Publicado: (2022)

Melatonin reduces lipid peroxidation and membrane viscosity
por: Reiter, Russel J., et al.
Publicado: (2014)

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
por: Simko, Fedor, et al.
Publicado: (2020)

Neurotoxins: Free Radical Mechanisms and Melatonin Protection
por: Reiter, Russel J., et al.
Publicado: (2010)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Interactions of melatonin, reactive oxygen species, and nitric oxide during fruit ripening: an update and prospective view
por: Corpas, Francisco J, et al.
Publicado: (2022)

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
por: Reiter, Russel J., et al.
Publicado: (2017)

Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
por: Loh, Doris, et al.
Publicado: (2022)

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
por: Shukla, Mayuri, et al.
Publicado: (2017)

Melatonin and Carbohydrate Metabolism in Plant Cells
por: Arnao, Marino B., et al.
Publicado: (2021)

Melatonin as an Antioxidant Agent in Stroke: An Updated Review
por: Wang, Junjie, et al.
Publicado: (2022)

Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration
por: Blasiak, Janusz, et al.
Publicado: (2016)

Melatonin: A Versatile Protector against Oxidative DNA Damage
por: Galano, Annia, et al.
Publicado: (2018)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Use of Melatonin in Oxidative Stress Related Neonatal Diseases
por: D’Angelo, Gabriella, et al.
Publicado: (2020)

Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
por: Zare, Hadis, et al.
Publicado: (2019)

Melatonin and cancer suppression: insights into its effects on DNA methylation
por: Davoodvandi, Amirhossein, et al.
Publicado: (2022)

Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
por: Tan, Dun-Xian, et al.
Publicado: (2022)

Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
por: Carbajo-Pescador, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o6qv96edgtpnt5plvg42976b06